Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension∗

This publication has 6 references indexed in Scilit:

• CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINE
  Annals of the New York Academy of Sciences, 1960
• Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanine
  Science, 1960
• The action of reserpine on the peripheral sympathetic system
  The Journal of Physiology, 1958
• Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanine
  Archives of Biochemistry and Biophysics, 1954
• Dopadecarboxylase
  The Science of Nature, 1939
• Fermentativer Abbau von l-Dioxyphenylalanin (Dopa) durch Niere
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1938